Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis
References (81)
Rheumatoid arthritis
Rheum Dis Clin North Am
(1990)- et al.
What is the natural history of rheumatoid arthritis?
Rheum Dis Clin North Am
(1993) - et al.
Bone changes in early rheumatoid arthritis
Best Pract Res Clin Rheumatol
(2001) - et al.
The costs of rheumatoid arthritis: An international long-term view
Semin Arthritis Rheum
(2000) - et al.
Pathogenesis of joint damage in rheumatoid arthritis: Evidence of a dominant role for interleukin-I
Baillieres Best Pract Res Clin Rheumatol
(1999) Uncoupling of inflammatory and destructive mechanisms in arthritis
Semin Arthritis Rheum
(2001)Biologic basis for interleukin-1 in disease
Blood
(1996)- et al.
Interleukin-1 receptor antagonist
Rheum Dis Clin North Am
(1998) - et al.
Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression
J Biol Chem
(1990) - et al.
Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis
Lancet
(1988)
Cytokine imbalance in the pathogenesis of rheumatoid arthritis: The role of interleukin-1 receptor antagonist
Semin Arthritis Rheum
(2001)
An interleukin 1 inhibitor affects both cell-associated interleukin 1-induced T cell proliferation and PGE2/collagenase production by human dermal fibroblasts and synovial cells
Immunobiology
(1990)
Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist
Cytokine
(1991)
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans
Cytokine
(1992)
The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis
Semin Arthritis Rheum
(2001)
Pathogenesis of joint damage in rheumatoid arthritis
J Rheumatol
(1999)
Mechanisms of bone loss in inflammatory arthritis: Diagnosis and therapeutic implications
Arthritis Res
(2000)
The links between joint damage and disability in rheumatoid arthritis
Rheumatology (Oxford)
(2000)
Predictors of joint damage in rheumatoid arthritis
APMIS
(1996)
Mortality in rheumatoid arthritis
Rev Rhum Engl Ed
(1999)
The underestimated long term medical and economic consequences of rheumatoid arthritis
Drugs
(1995)
Premature mortality in patients with rheumatoid arthritis: Evolving concepts
Arthritis Rheum
(2001)
Joint erosions and patients with early rheumatoid arthritis
Br J Rheumatol
(1995)
Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis
Arthritis Rheum
(1992)
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of Genant and Larsen scores
Arthritis Rheum
(2000)
Radiographic progression in rheumatoid arthritis: A long-term prospective study of 109 patients
Arthritis Rheum
(1998)
Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis
Rheumatology (Oxford)
(1999)
Rheumatoid arthritis: Treat now, not later!
Ann Intern Med
(1996)
Early aggressive DMARD therapy: The key to slowing disease progression in rheumatoid arthritis
Scand J Rheumatol Suppl
(1999)
Cytokine pathways and joint inflammation in rheumatoid arthritis
N Engl J Med
(2001)
Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis
Ann Rheum Dis
(2000)
Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis
Arthritis Rheum
(1995)
Prospects for autoimmune disease: Research advances in rheumatoid arthritis
JAMA
(2001)
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis
Rheumatol Int
(1982)
Isolation of an interleukin-1-like factor from human joint effusions
Arthritis Rheum
(1983)
Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids
Clin Exp Immunol
(1984)
The role of interleukin-1 in disease
N Engl J Med
(1993)
Treatment of rheumatoid arthritis with IL-1 inhibitors
Springer Semin Immunopathol
(1998)
Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid
Arthritis Rheum
(1986)
Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis
Rheumatol Int
(1985)
Cited by (153)
Progression of pyoderma gangrenosum with angioinvasive fungus
2021, JAAD Case ReportsAdvances in immunotherapy for COVID-19: A comprehensive review
2021, International ImmunopharmacologyStructure-based Development of Human Interleukin-1β-Specific Antibody That Simultaneously Inhibits Binding to Both IL-1RI and IL-1RAcP
2021, Journal of Molecular BiologyRole of Bioactive Compounds, Novel Drug Delivery Systems, and Polyherbal Formulations in the Management of Rheumatoid Arthritis
2024, Combinatorial Chemistry and High Throughput ScreeningAnakinra Removal by Continuous Renal Replacement Therapy: An Ex Vivo Analysis
2023, Critical Care Explorations
Copyright © 2004 Published by Elsevier Inc.